Michael Scott Segal - Net Worth and Insider Trading

Michael Scott Segal Net Worth

The estimated net worth of Michael Scott Segal is at least $28,909 dollars as of 2024-04-28. Michael Scott Segal is the Director of NetSuite Inc and owns about 320 shares of NetSuite Inc (N) stock worth over $28,909. Michael Scott Segal is also the Director of Apotheca Biosciences Inc and owns about 2,711 shares of Apotheca Biosciences Inc (CBDC) stock worth over $1. Details can be seen in Michael Scott Segal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Scott Segal has not made any transactions after 2019-08-09 and currently still holds the listed stock(s).

Transaction Summary of Michael Scott Segal

To

Michael Scott Segal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Scott Segal owns 1 companies in total, including Crescent Capital BDC Inc (CCAP) .

Click here to see the complete history of Michael Scott Segal’s form 4 insider trades.

Insider Ownership Summary of Michael Scott Segal

Ticker Comapny Transaction Date Type of Owner
CCAP Crescent Capital BDC Inc 2022-12-31 director

Michael Scott Segal Latest Holdings Summary

Michael Scott Segal currently owns a total of 2 stocks. Among these stocks, Michael Scott Segal owns 320 shares of NetSuite Inc (N) as of July 15, 2015, with a value of $28,909 and a weighting of 100%. Michael Scott Segal also owns 2,711 shares of Apotheca Biosciences Inc (CBDC) as of August 9, 2019, with a value of $1 and a weighting of 0%.

Latest Holdings of Michael Scott Segal

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
N NetSuite Inc 2015-07-15 320 90.34 28,909
CBDC Apotheca Biosciences Inc 2019-08-09 2,711 0.00 1

Holding Weightings of Michael Scott Segal


Michael Scott Segal Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Scott Segal has made a total of 0 transactions in NetSuite Inc (N) over the past 5 years. The most-recent trade in NetSuite Inc is the acquisition of 320 shares on July 15, 2015, which cost Michael Scott Segal around $6,400.

According to the SEC Form 4 filings, Michael Scott Segal has made a total of 3 transactions in Apotheca Biosciences Inc (CBDC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Apotheca Biosciences Inc is the acquisition of 149 shares on August 9, 2019, which cost Michael Scott Segal around $2,949.

Insider Trading History of Michael Scott Segal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Scott Segal Trading Performance

GuruFocus tracks the stock performance after each of Michael Scott Segal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Scott Segal is -21.15%. GuruFocus also compares Michael Scott Segal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Scott Segal within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Scott Segal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Scott Segal

Average Return

-29.18%

Average return per transaction

Outperforming Transactions

25%

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.37 -21.15 -53.94 -29.18 -77.88
Relative Return to S&P 500(%) -9.29 -21.99 -57.61 -35.67 -99.73

Michael Scott Segal Ownership Network

Ownership Network List of Michael Scott Segal

No Data

Ownership Network Relation of Michael Scott Segal


Michael Scott Segal Owned Company Details

What does Crescent Capital BDC Inc do?

Who are the key executives at Crescent Capital BDC Inc?

Michael Scott Segal is the director of Crescent Capital BDC Inc. Other key executives at Crescent Capital BDC Inc include Secretary George Hawley , Chief Financial Officer Gerhard Lombard , and Senior Vice President Erik G Barrios .

Crescent Capital BDC Inc (CCAP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Crescent Capital BDC Inc (CCAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Crescent Capital BDC Inc (CCAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Crescent Capital BDC Inc (CCAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crescent Capital BDC Inc Insider Transactions

No Available Data

Michael Scott Segal Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Scott Segal. You might contact Michael Scott Segal via mailing address: C/o Crescent Capital Bdc, Inc., 11100 Santa Monica Blvd., Suite 2000, Los Angeles Ca 90025.

Discussions on Michael Scott Segal

No discussions yet.